-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.

Focus on Canine Cancer – Media Education Session
- Share
- Tweet
- Share on Facebook
- Share

Media Education Session, featuring Volition CMO, Heather Wilson-Robles, DVM, DACVIM (Oncology), Dr. Sue Ettinger, DVM, DACVIM (Oncology), and Dr. Lisa Lippman, DVM
Watch our video for:
- Canine Cancer overview
- Cancer Screening: its importance
- On overview of nucleosomes and why we measure them?
- Case studies of Nu.Q® Vet
- Tips for vets and pet owners
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields